-
Maomao Cao1，He Li1，Dianqin Sun1，Siyi He1，Xinxin Yan1，Fan Yang1，Shaoli Zhang1，Changfa Xia1，Lin Lei2，Ji Peng2，Wanqing Chen1（Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College/Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement；Department of Cancer Prevention and Control,Shenzhen Center for Chronic Disease Control）.Current cancer burden in China：epidemiology, etiology, and prevention[J].癌症生物学与医学(英文版),2022,第8期
-
Jingyao Chen1，Xiangyu Pan1，Feifei Na2，Xuelan Chen1，Chong Chen1（State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University；Department of Thoracic Oncology, West China Hospital, Sichuan University）.Epigenetic reprogramming in small cell lung cancer[J].Cancer Biology & Medicine,2022,第8期
-
Junling Shen1，Jilong Yang，Lei Sang1，Rui Sun1，Weiyu Bai1，Chao Wang，Yan Sun，Jianwei Sun1（Center for Life Sciences, School of Life Sciences, State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Yunnan University；Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer）.PYK2 mediates the BRAF inhibitor （vermurafenib）-induced invadopodia formation and metastasis in melanomas[J].癌症生物学与医学(英文版),2022,第8期
-
Yangyang Kong，Chang Xu，Xiaohui Sun，Hao Sun，Xiaotong Zhao，Ningning He，Kaihua Ji，Qin Wang，Liqing Du，Jinhan Wang，Manman Zhang，Yang Liu，Yan Wang，Qiang Liu（Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences＆Peking Union Medical College）.BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair[J].癌症生物学与医学(英文版),2022,第8期
-
Wenhui Wu1，Zongchao Liu1，Zhexuan Li1，Weidong Liu2，Lanfu Zhang，Yang Zhang1，Tong Zhou1，Weicheng You1，Kaifeng Pan1，Wenqing Li1（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital and Institute, Haidian District；Linqu County Public Health Bureau；Linqu County People’s Hospital）.Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions：a prospective follow-up study[J].癌症生物学与医学(英文版),2022,第8期
-
Yujiao Wang1，Xi Jiao1，Shuang Li2，Huan Chen3，Xin Wei4，Chang Liu1，Jifang Gong1，Xiaotian Zhang1，Xicheng Wang1，Zhi Peng1，Changsong Qi1，Zhenghang Wang1，Yanni Wang1，Na Zhuo1，Jianling Zou1，Henghui Zhang5，Jian Li1，Lin Shen1，Zhihao Lu1（Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital＆Institute；Department of Gastric＆Colorectal Surgery,The First Hospital of Jilin University；Genecast Precision Medicine Technology Institute；Life Sciences Institute, Zhejiang University；Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University）.Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer[J].癌症生物学与医学(英文版),2022,第8期
-
Minghan Qiu1,2，Shan Wu1,2，Xinrui Chen1,2，Huaqing Wang1,2（Department of Oncology, Tianjin Union Medical Center, Nankai University；The Institute of Translational Medicine, Tianjin Union Medical Center, Nankai University）.Update on diffuse large B-cell lymphoma：highlights from the 2022 ASCO Annual Meeting[J].癌症生物学与医学(英文版),2022,第8期
-
Qiong Wang1,2,3，Zean Li1,3，Jin Yang3,4，Shirong Peng1,3，Qianghua Zhou1,3，Kai Yao5，Wenli Cai6，Zhongqiu Xie2，Fujun Qin2，Hui Li2，Xu Chen1,3，Kaiwen Li1,3，Hai Huang1,3,7（Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University；Department of Pathology, School of Medicine, University of Virginia, Charlottesville；Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University；Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University；Department of Urology, Sun Yat-sen University Cancer Center；Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston；Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital）.Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer[J].癌症生物学与医学(英文版),2022,第8期
-
Cuicui Zhang，Jing Wang，Xinyue Wang，Zhaoting Meng，Ying Cheng2，Kai Li（Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer；Jilin Cancer Hospital）.Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer[J].癌症生物学与医学(英文版),2022,第8期
-
Ting He1,2，Yinglei Gao1，Yanfen Fang1，Yangming Zhang3，Shuwei Zhang2,3，Fajun Nan3，Jian Ding1,2，Yi Chen1,2（Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences；University of Chinese Academy of Sciences；State Key Laboratory of Drug Research,the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences）.The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer[J].癌症生物学与医学(英文版),2022,第8期
-
Hwi-Won Lee1,2，Dan Huang2,3，Woo-Kyoung Shin2,3，Katherine de la Torre1,2，Minkyo Song2，Aesun Shin2，Jong-Koo Lee4，Daehee Kang2,3（Department of Biomedical Sciences, Seoul National University Graduate School；Department of Preventive Medicine, Seoul National University College of Medicine；Integrated Major in Innovative Medical Science, Seoul National University Graduate School；Department of Family Medicine, Seoul National University Hospital）.Frequent low dose alcohol intake increases gastric cancer risk：the Health Examinees-Gem （HEXA-G） study[J].癌症生物学与医学(英文版),2022,第8期
-
Yan Li1，Lihong Fan，Jianming Zheng3，Xiu Nie1，Yu Sun4，Qin Feng4，Shenyi Lian4，Wenqi Bai5，Weijing Cai6，Yanan Yang7，Bo Su8，Yanfeng Xi9，Dongmei Lin4（Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology；Department of Respiration Medicine, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University；Department of Pathology, Changhai Hospital of Shanghai；Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital＆Institute；Department of Colorectal Surgery, Shanxi Cancer Hospital；Shanghai Tongshu Biotechnology Co., Ltd；Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester；Central Laboratory, Shanghai Pulmonary Hospital,School of Medicine, Tongji University；Department of Pathology, Shanxi Cancer Hospital）.Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer[J].癌症生物学与医学(英文版),2022,第8期
-
Ye Tian，Qiang Li，Yuan Pan（Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer）.Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer[J].癌症生物学与医学(英文版),2022,第8期
-
Jingjing Wu，Fenghua Gao，Wenhua Wang，Xudong Zhang，Meng Dong，Lei Zhang，Xin Li，Ling Li，Zhenchang Sun，Xinhua Wang，Xiaorui Fu，Linan Zhu，Mengjie Ding，Songtao Niu，Zhaoming Li，Yu Chang，Feifei Nan，Jiaqian Yan，Hui Yu，Xiaolong Wu，Zhiyuan Zhou，Jieming Zhang，Mingzhi Zhang（Cancer Research Institute）.Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma：a prospective phase Ⅱ trial[J].癌症生物学与医学(英文版),2022,第7期
-
Hongquan Wang，Shuang Wu，Yan Wang，Bo Tang（Department of Pancreatic Cancer）.Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF[J].癌症生物学与医学(英文版),2022,第7期
-
Liao Wang1,2，Yinghui Sun3，Xijie Liu3，Hongjuan Li3，Chang Lu3，Ronghui Yang1,2，Chuanzhen Yang1,2，Binghui Li1,2（Department of Biochemistry and Molecular Biology；Advanced Innovation Center for Human Brain Protection；Shouyao Holdings Co.）.SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation[J].癌症生物学与医学(英文版),2022,第7期
-
Duo Zuo，Yongzi Chen，Xinwei Zhang，Zhuozhi Wang3，Wenna Jiang，Fan Tang4，Runfen Cheng，Yi Sun6，Lu Sun6，Li Ren，Rui Liu（Department of Clinical Laboratory；Department of Tumor Cell Biology；School of Biomedical Engineering；Department of Pathology；Department of Pathology；School of Pharmacy；Department of Gastrointestinal Medical Oncology）.Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma[J].癌症生物学与医学(英文版),2022,第7期
-
Tingting Feng1，Jing Wang，Kai Cheng3，Qiqi Lu4,5，Ru Zhao1，Shiguan Wang5,6，Qingyun Zhang5，Luna Ge5，Jihong Pan5，Guanhua Song7，Lin Wang5,8（Department of Pathology；Department of Pathology；Department of PET-CT；The Second Hospital；Biomedical Sciences College&Shandong Medicinal Biotechnology Centre；Department of Biochemistry and Molecular Biology；Institute of Basic Medicine；Department of Oncology）.IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation[J].癌症生物学与医学(英文版),2022,第7期
-
Yu Han1，Yuming Yang1,2，Qiuyang Sun3，Bin Li3，Caixia Yue1,4，Yanlei Liu1，Jesús M.de la Fuente1,5，Daxiang Cui1,2（Institute of Nano Biomedicine and Engineering；National Engineering Center for Nanotechnology；Department of Neurosurgery；School of Biomedical Engineering；Instituto de Nanociencia de Aragon（INA））.Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages[J].癌症生物学与医学(英文版),2022,第7期
-
Haixin Li1，Hongkun Liu1，Kexin Chen2（Cancer Biobank；Department of Epidemiology and Biostatistics）.Living biobank-based cancer organoids：prospects and challenges in cancer research[J].癌症生物学与医学(英文版),2022,第7期
-
Leyi Yao1,2,3，Qian Zhao4，Ding Yan1,2，Ziying Lei1，Yali Hao1,2，Jinghong Chen2，Qian Xue1,2，Xiaofen Li1,2，Qingtian Huang1,2，Daolin Tang5，Q.Ping Dou6，Xin Chen1,2，Jinbao Liu1,2,3（Affiliated Cancer Hospital&Institute of Guangzhou Medical University；Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation；Institute of Digestive Disease of Guangzhou Medical University；School of Public Health；Department of Surgery；Barbara Ann Karmanos Cancer Institute and Departments of Oncology）.Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells[J].癌症生物学与医学(英文版),2022,第7期
-
Wuyin Wang1，Lu Zhang1，Zhijun Sun1,2（The State Key Laboratory Breeding Base of Basic Science of Stomatology（Hubei-MOST）&Key Laboratory of Oral Biomedicine Ministry of Education；Department of Oral Maxillofacial-Head Neck Oncology）.Eliciting pyroptosis to fuel cancer immunotherapy：mechanisms and strategies[J].癌症生物学与医学(英文版),2022,第7期
-
Junjie Li1,2，Jingyi Cheng3，Guangyu Liu1,2，Yifeng Hou1,2，Genghong Di1,2，Benglong Yang1,2，Yizhou Jiang1,2，Liang Huang1,2，Feilin Qu1,2，Sheng Chen1,2，Yan Wang1,2，Keda Yu1,2，Zhimin Shao1,2（Department of Breast Surgery；Key Laboratory of Breast Cancer in Shanghai；Department of Nuclear Medicine）.Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer：a prospective phase Ⅱ trial[J].癌症生物学与医学(英文版),2022,第7期
-
Yi Xie1,2，Bing Wang3，Liqing Du4，Yan Wang4，Chang Xu4，Hong Zhang1,2，Kaixue Wen5，Qiang Liu4，Takanori Katsube3（Institute of Modern Physics；Advanced Energy Science and Technology Guangdong Laboratory；National Institute of Radiological Sciences；Institute of Radiation Medicine；Shanxi Bethune Hospital）.ANTP-SMACN7 fusion peptide alone induced high linear energy transfer irradiation radiosensitization in non-small cell lung cancer cell lines[J].癌症生物学与医学(英文版),2022,第7期
-
Jianping Dou，Zhigang Cheng，Zhiyu Han，Fangyi Liu，Zhen Wang，Xiaoling Yu，Jie Yu，Ping Liang（Department of Interventional Ultrasound）.Microwave ablation vs. surgical resection for treatment na?ve hepatocellular carcinoma within the Milan criteria：a follow-up of at least 5 years[J].癌症生物学与医学(英文版),2022,第7期
-
Yangling Li，Dongmei Zhou，Shuang Xu，Mingjun Rao，Zuoyan Zhang，Linwen Wu，Chong Zhang，Nengming Lin（Department of Clinical Pharmacology；Department of Clinical Pharmacology；Institute of Pharmacology；School of Medicine）.Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors[J].癌症生物学与医学(英文版),2022,第7期
-
Tao Yan1,2，Lingxiang Yu3，Ning Zhang1，Caiyun Peng1，Guodong Su1，Yi Jing1，Linzhi Zhang1，Tong Wu1，Jiamin Cheng1，Qian Guo2，Xiaoliang Shi4，Yinying Lu1,2,5（Comprehensive Liver Cancer Center；The Second School of Clinical Medicine；The Second Department of Hepatobiliary Surgery；Shanghai OrigiMed Co.；National Clinical Medical Research Center for Infectious Diseases）.The advanced development of molecular targeted therapy for hepatocellular carcinoma[J].癌症生物学与医学(英文版),2022,第6期
-
Jianbin Li，Zefei Jiang（Senior Department of Oncology）.Chinese Society of Clinical Oncology Breast Cancer（CSCO BC） guidelines in 2022：stratification and classification[J].癌症生物学与医学(英文版),2022,第6期
-
Li Dong7；Hailian Zhang2,3,4；Huan Zhang3；Yingnan Ye7；Yanan Cheng7；Lijuan Li3；Lijuan Wei3；Lei Han7；Yandong Cao6；Shixia Li3；Xishan Hao7,3；Juntian Liu2,3；Jinpu Yu7（Cancer Molecular Diagnostics Core , Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education；The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education；Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education；Department of Oncology, Tianjin Third Central Hospital, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry；Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education；Analyses Technology Co.Ltd.；Cancer Molecular Diagnostics Core , Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education）.The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families[J].癌症生物学与医学(英文版),2022,第6期
-
Chunli Zhang1，Wei Wan2，Shuai Zhang1，Jingwen Wang3，Ru Feng1，Jiangtao Li1，Junyue Chai4，Hebing Zhou5，Liru Wang6，Yuping Zhong7，Xiaodong Mo，Mengzhu Shen，Hongmei Jing2，Hui Liu1（Department of Hematology；Department of Hematology；Department of Hematology；Department of Hematology；Department of Hematology；Department of Hematology；Department of Hematology；Peking University People’s Hospital）.Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients：a retrospective multicenter cohort study in China[J].癌症生物学与医学(英文版),2022,第6期
|